Kanagawa, Japan

Saburo Sone




Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Yokohama, JP (2003 - 2013)
  • Kanagawa, JP (1999 - 2015)

Company Filing History:


Years Active: 1999-2015

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Saburo Sone: Innovator in Hepatitis C Research

Introduction

Saburo Sone is a prominent inventor known for his significant contributions to the field of hepatitis C research. He is based in Kanagawa, Japan, and holds a total of nine patents. His work has been instrumental in advancing the understanding and treatment of hepatitis C virus (HCV).

Latest Patents

One of his latest patents involves a modified human hepatitis C virus genomic RNA that can be autonomously replicated. This invention provides a modified hepatitis C virus genomic RNA, which includes nucleotide sequences from two or more types of hepatitis C viruses. It comprises essential coding sequences and can replicate independently. Another notable patent focuses on a nucleic acid construct containing the full-length genome of the human hepatitis C virus. This invention outlines methods for efficiently replicating RNA containing the full-length HCV genomic sequence and producing HCV virus particles using a cell culture system. Additionally, it relates to a hepatitis C vaccine and an antibody against hepatitis C virus particles.

Career Highlights

Throughout his career, Saburo Sone has worked with esteemed organizations such as Toray Industries, Inc. and the Tokyo Metropolitan Institute of Medical Science. His research has significantly impacted the scientific community's approach to hepatitis C.

Collaborations

He has collaborated with notable coworkers, including Takaji Wakita and Jun-ichi Tanabe, further enhancing the depth and breadth of his research contributions.

Conclusion

Saburo Sone's innovative work in hepatitis C research has led to important advancements in the field. His patents and collaborations reflect his commitment to improving health outcomes related to hepatitis C.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…